Feasibility and efficacy of a mass switch from ranibizumab (Lucentis) to bevacizumab (Avastin) for treatment of neovascular age-related macular degeneration

Por Andreoli, Michael T., Pinnolis, Michael, Kieser, Troy, Sun, Jennifer, Andreoli, Christopher M.
Publicado no Digit J Ophthalmol (2015)